Merck & Co Inc (MRK)
99.85
+2.41
(+2.47%)
USD |
NYSE |
Nov 21, 16:00
99.94
+0.09
(+0.09%)
After-Hours: 20:00
Merck Shareholders Equity (Quarterly): 44.50B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 44.50B |
June 30, 2024 | 43.58B |
March 31, 2024 | 40.36B |
December 31, 2023 | 37.58B |
September 30, 2023 | 41.25B |
June 30, 2023 | 38.69B |
March 31, 2023 | 46.83B |
December 31, 2022 | 45.99B |
September 30, 2022 | 44.46B |
June 30, 2022 | 43.24B |
March 31, 2022 | 40.88B |
December 31, 2021 | 38.18B |
September 30, 2021 | 35.79B |
June 30, 2021 | 33.29B |
March 31, 2021 | 26.94B |
December 31, 2020 | 25.32B |
September 30, 2020 | 29.19B |
June 30, 2020 | 27.64B |
March 31, 2020 | 26.20B |
December 31, 2019 | 25.91B |
September 30, 2019 | 26.84B |
June 30, 2019 | 27.64B |
March 31, 2019 | 27.54B |
December 31, 2018 | 26.70B |
September 30, 2018 | 32.42B |
Date | Value |
---|---|
June 30, 2018 | 32.53B |
March 31, 2018 | 33.67B |
December 31, 2017 | 34.34B |
September 30, 2017 | 38.25B |
June 30, 2017 | 39.46B |
March 31, 2017 | 39.84B |
December 31, 2016 | 40.09B |
September 30, 2016 | 43.74B |
June 30, 2016 | 43.36B |
March 31, 2016 | 43.81B |
December 31, 2015 | 44.68B |
September 30, 2015 | 45.59B |
June 30, 2015 | 46.45B |
March 31, 2015 | 47.76B |
December 31, 2014 | 48.65B |
September 30, 2014 | 45.22B |
June 30, 2014 | 48.36B |
March 31, 2014 | 49.98B |
December 31, 2013 | 49.76B |
September 30, 2013 | 47.42B |
June 30, 2013 | 47.50B |
March 31, 2013 | 53.03B |
December 31, 2012 | 53.02B |
September 30, 2012 | 55.75B |
June 30, 2012 | 55.19B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
25.32B
Minimum
Dec 2020
46.83B
Maximum
Mar 2023
36.79B
Average
38.44B
Median
Shareholders Equity (Quarterly) Benchmarks
Amgen Inc | 7.527B |
Johnson & Johnson | 70.16B |
Eli Lilly and Co | 14.24B |
Pfizer Inc | 92.29B |
Moderna Inc | 11.93B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 117.53B |
Total Liabilities (Quarterly) | 72.97B |
Debt to Equity Ratio | 0.8568 |
Current Ratio | 1.364 |
Net Debt Paydown Yield | -0.08% |